![](/img/cover-not-exists.png)
Half-Dose Valcyte for 1 Month in CMV Intermediate Risk Kidney Transplant Recipients… A Cost-Effective Alternative?
Gillespie, M., Lee, S., Shihab, F., Smith, L.Volume:
98
Journal:
Transplantation
DOI:
10.1097/00007890-201407151-02618
Date:
July, 2014
File:
PDF, 260 KB
2014